跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ammeltz - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ammeltz
Approved
STANDARD
Ammeltz
Sendai Kobayashi Pharm. Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
6338b525366dee53
Company
Sendai Kobayashi Pharm. Co., Ltd.
Type
Standard
Approval Details
Approval Id
6338b525366dee53
Drug Approval Philippines Name
Ammeltz
Product Name
Ammeltz
Registration Number
DRHR-710
Brand Name
Ammeltz
Generic Name
Methyl Salicylate + L-Menthol + dL-Camphor + Vanillylamide Nonylate
Dosage Form
Liniment
Dosage Strength
5g/5.2g/5.2g/8mg per 100 mL
Manufacturer
Sendai Kobayashi Pharm. Co., Ltd.
Importer
Kobayashi Pharmaceutical (Singapore) Pte. Ltd.
Distributor
Philusa Corporation
Issuance Date
25 August 2024
Expiry Date
26 January 2030
Pharmacologic Category
Counterirritant
Classification
Household Remedy (HR)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
6338b525366dee53
Type
Standard
Back to Philippines FDA Approvals